But Bannet was a veteran of all this, alert to all the little strategic opacities that were built into Derek’s typical talk to stockholders or potential investors. Something like sixty percent of biotech start-ups failed, so the danger of losing some or all of an investment to bankruptcy was very real. No way Derek could finesse him. They would have to come clean and hope he liked what he saw.

Leo gazed out the window at the foggy Pacific, listening to Derek go on. Unbroken waves wrapped around La Jolla Point and pulsed into the cove. The huge apartment block at the end of La Jolla Point blocked his view west, reminding him that big money could accomplish some unlikely things.

Derek finished leading Bannet through a series of financial spreadsheets on his laptop, unable to disguise their tale of woe. Bad profit and loss; layoffs; sale of some subsidiary contracts, even some patents, their crown jewels; empty coffers.

“We’ve had to focus on the things that we think are really the most important,” Derek admitted. “It’s made us more efficient, that’s for sure. But it means there really isn’t any fat anywhere, no resources we can put to the task, even though it’s got such incredible potential. So, it seemed like it was time to ask for some outside funding help, with the idea that the financing now would be so crucial that the returns to the investor could and should be really significant.”

“Uh-huh,” Bannet said, though it wasn’t clear what he was agreeing with. He made thoughtful clucking sounds as he scanned the spreadsheets, murmuring “Um-hmmm, um-hmmm,” in a sociable way, but now that he was thinking about the information in the spreadsheets, his face betrayed an almost burning intensity. This guy was definitely one of the passionate ones, Leo saw.

“Tell me about this algorithm,” he said finally.

Derek looked to Leo, who said, “Well, the mathematician developing it is a recent hire at Torrey Pines, and he’s been collaborating with our lab to test a set of operations he’s developed, to see how well they can predict the proteins associated with any given gene, and as you can see” clicking his own laptop screen to the first of the project report slides “it’s been really good at predicting them in certain situations,” pointing to them on the screen’s first slide.

“And how would this affect the targeted delivery system you’re working on?”

“Well, right now it’s helping us to find proteins with ligands that bind better to their receptor ligands in target organ cells. It’s also helping us test for proteins that we can more successfully shove across cell walls, using the hydrodynamic methods we’ve been investigating for the past few months.” He clicked ahead to the slide that displayed this work’s results, trying to banish Brian’s and Marta’s names from his mind, he definitely did not want to be calling it the Popping Eyeball Method, the Exploding Mouse Method. “As you can see,” pointing to the relevant results, “saturation has been good in certain conditions.” This seemed a little weak, and so he added, “The algorithm is also proving to be very successful in guiding work we’ve been doing with botanists on campus, on algal designs.”

“How does that connect with this?”

“Well, it’s for plant engineering.”

Bannet looked at Derek.

Derek said, “We plan to use it to pursue the improvement of targeted delivery. Clearly the method is robust, and people can use it in a wide variety of applications.”

But there was no hiding it, really. Their best results so far were in an area that would not necessarily ever become useful to human medicine. And yet human medicine was what Torrey Pines Generique was organized to do. Biocal also.

“It looks really promising, eh?” Derek said. “It could be that it’s an algorithm that is more than just a mathematical exercise, more like a law of nature. The grammar of how genes express themselves. It could mean a whole suite of patents when the applications are all worked out.”

“Um-hmmm,” Bannet said, looking down again at Derek’s laptop, which was still at the financial page. Almost pathetic, really; except it must have been a fairly common story, so that Bannet would not necessarily be shocked or put off. He would simply be considering the investment on a risk-adjusted basis, which would take the present situation into account.

Finally he said, “It looks very interesting. Of course it’s always a bit of a sketchy feeling, when you’ve gotten to the point of having all your eggs in one basket like this. But sometimes one is all you need. The truth is, I don’t really know yet.”

Derek nodded in reluctant agreement. “Well, you know. We believe very strongly in the importance of therapies for the most serious diseases, and so we concentrated on that, and now we kind of have to, you know, go on from there with our best ideas. That’s why we’ve focused on the HDL upgrade. With this targeted delivery, it could be worth billions.”

“And the HDL upgrade…”

“We haven’t published yet. We’re still looking into the patent situation there.”

Leo’s stomach tightened, but he kept his face blank.

Bannet was even blanker; still friendly and sympathetic enough, but with that piercing eye. “Send me the rest of your business plan, and all the scientific publications that relate to this. All the data. I’ll discuss it with some of my partners here. It seems like the kind of thing that I’d like to get my partners’ inputs on. That’s not unusual, it’s just that it’s bigger than what I usually do on my own. And some of my colleagues are into agropharmacy stuff.”

“Sure,” Derek said, handing over a glossy folder of material he had already prepared. “I understand. We can come back and talk to them too if you like, answer any questions.”

“That’s good, thanks.” Bannet put the folder on the table. With a few more pleasantries and a round of handshaking, Derek and Leo were ushered out.

Leo found he had no idea whether the meeting had gone well or poorly. And would that be a good sign or a bad one?

VII

Tit for Tat

The Earth’s atmosphere now contains a percentage of carbon dioxide and other greenhouse gases that is higher than it has been since the end of the Cretaceous. This means more heat from the sun is being trapped in our air, and the high-pressure cells we saw this year are bigger, warmer, and loft higher in the tropical atmosphere. Many common jet-stream patterns have been disrupted, and the storms spiraling out of the Tropics have gained in both frequency and intensity. The hurricane season in the Atlantic ran from April to November, and there were eight hurricanes and six tropical storms. Typhoons in the East Pacific happened all year, twenty-two all told. Mass flooding resulted, but it should be noted that in other regions droughts have been breaking records.

So the effects have been various, but the changes are general and pervasive, and the damage for the year was recently estimated at six hundred billion dollars, with deaths in the thousands. So far the United States has escaped major catastrophe, and attention to the problem has not been one of the administration’s central concerns. “In a healthy economy the weather isn’t important,” the President remarked. But the possibility is there that the added energy in the atmosphere could trigger what climatologists call abrupt climate change. How that might begin, no one can be sure.

ANNA FLEW through the blur of a midweek day. Up and off, Metro to the office; pound the keys, wrestling with some faulty data from an NSF educational outreach program, the spreadsheet work eating up hours like minutes. Stop to pump, then to eat at her desk (it felt a little too weird to eat and pump at the same time), all the while data wrangling. Then a look at an e-mail from Drepung and Sucandra about their grant proposals.


Перейти на страницу:
Изменить размер шрифта: